Caspofungin Acetate Patent Expiration
Caspofungin Acetate was first introduced by Merck And Co Inc
Caspofungin Acetate Patents
Given below is the list of patents protecting Caspofungin Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Caspofungin Acetate | US9636407 | Caspofungin acetate formulations | Dec 21, 2032 | Fresenius Kabi Usa |
| Cancidas |
US5952300 (Pediatric) | Antifungal compositions |
Sep 28, 2017
(Expired) | Merck |
| Cancidas |
US6136783 (Pediatric) | Antifungal compositions |
Sep 28, 2017
(Expired) | Merck |
| Cancidas | US5952300 | Antifungal compositions |
Mar 28, 2017
(Expired) | Merck |
| Cancidas | US6136783 | Antifungal compositions |
Mar 28, 2017
(Expired) | Merck |
| Cancidas |
US5514650 (Pediatric) | Aza cyclohexapeptide compounds |
Jul 26, 2015
(Expired) | Merck |
| Cancidas | US5514650 | Aza cyclohexapeptide compounds |
Jan 26, 2015
(Expired) | Merck |
| Cancidas |
US5378804 (Pediatric) | Aza cyclohexapeptide compounds |
Sep 16, 2013
(Expired) | Merck |
| Cancidas |
US5792746 (Pediatric) | Aza cyclohexapeptide compounds |
Sep 16, 2013
(Expired) | Merck |
| Cancidas | US5378804 | Aza cyclohexapeptide compounds |
Mar 16, 2013
(Expired) | Merck |
| Cancidas | US5792746 | Aza cyclohexapeptide compounds |
Mar 16, 2013
(Expired) | Merck |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Caspofungin Acetate's patents.
Latest Legal Activities on Caspofungin Acetate's Patents
Given below is the list recent legal activities going on the following patents of Caspofungin Acetate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 02 Nov, 2020 | US9636407 |
| Recordation of Patent Grant Mailed Critical
| 02 May, 2017 | US9636407 |
| Patent Issue Date Used in PTA Calculation Critical
| 02 May, 2017 | US9636407 |
| Email Notification Critical
| 13 Apr, 2017 | US9636407 |
| Issue Notification Mailed Critical
| 12 Apr, 2017 | US9636407 |
| Dispatch to FDC | 29 Mar, 2017 | US9636407 |
| Application Is Considered Ready for Issue Critical
| 28 Mar, 2017 | US9636407 |
| Issue Fee Payment Verified Critical
| 27 Mar, 2017 | US9636407 |
| Issue Fee Payment Received Critical
| 27 Mar, 2017 | US9636407 |
| Mail PUBS Letter Withdrawing a Notice Requiring Inventors Oath or Declaration | 15 Mar, 2017 | US9636407 |
Caspofungin Acetate's Family Patents
